|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.79 EUR | -0.21% |
|
+2.37% | +37.65% |
| Dec. 10 | Berenberg Revises Delivery Hero Price Target, Earnings Estimates Amid Higher Spending Commitment | MT |
| Dec. 08 | PROSUS : Buy rating from Barclays | ZD |
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
Return on Assets | -1.32 | -0.65 | -0.53 | -0.16 | 0.17 | ||||
Return on Total Capital | -1.42 | -0.7 | -0.57 | -0.18 | 0.19 | ||||
Return On Equity % | 20.41 | 39.68 | 19.93 | 15.97 | 27.04 | ||||
Return on Common Equity | 20.64 | 40.07 | 20.14 | 16.02 | 27.07 | ||||
Margin Analysis | |||||||||
Gross Profit Margin % | 32.47 | 30.03 | 28.74 | 40.64 | 42.53 | ||||
SG&A Margin | 51.09 | 40.18 | 38.99 | 43.68 | 39.92 | ||||
EBITDA Margin % | -15.99 | -7.49 | -8 | -0.15 | 4.49 | ||||
EBITA Margin % | -16.65 | -8.21 | -8.59 | -1.76 | 3.84 | ||||
EBIT Margin % | -18.82 | -9.58 | -10.11 | -3.05 | 3.05 | ||||
Income From Continuing Operations Margin % | 144.62 | 270.81 | 164.44 | 125.48 | 202.5 | ||||
Net Income Margin % | 145.6 | 272.84 | 175.4 | 120.83 | 200.44 | ||||
Net Avail. For Common Margin % | 145.6 | 272.84 | 166 | 125.77 | 202.51 | ||||
Normalized Net Income Margin | 75.91 | 78.78 | 51.33 | 35.4 | 63.95 | ||||
Levered Free Cash Flow Margin | 36.46 | -9.77 | -31.73 | -7.75 | 10.7 | ||||
Unlevered Free Cash Flow Margin | 39.66 | -6.11 | -25.71 | -1.38 | 16.26 | ||||
Asset Turnover | |||||||||
Asset Turnover | 0.11 | 0.11 | 0.08 | 0.09 | 0.09 | ||||
Fixed Assets Turnover | 12.48 | 13.12 | 9.42 | 9.31 | 11.77 | ||||
Receivables Turnover (Average Receivables) | 39.2 | 32.23 | 27.92 | 9.39 | 9.13 | ||||
Inventory Turnover (Average Inventory) | 12.94 | 12.15 | 10.35 | 10.96 | 13.56 | ||||
Short Term Liquidity | |||||||||
Current Ratio | 1.78 | 3.46 | 5.31 | 4.77 | 3.54 | ||||
Quick Ratio | 1.69 | 3.33 | 5.07 | 4.51 | 3.39 | ||||
Operating Cash Flow to Current Liabilities | 0.04 | -0.14 | -0.03 | 0.23 | 0.31 | ||||
Days Sales Outstanding (Average Receivables) | 9.31 | 11.32 | 13.07 | 38.96 | 39.99 | ||||
Days Outstanding Inventory (Average Inventory) | 28.21 | 30.05 | 35.27 | 33.39 | 26.92 | ||||
Average Days Payable Outstanding | 76.63 | 78.15 | 115.16 | 139.22 | 146.24 | ||||
Cash Conversion Cycle (Average Days) | -39.11 | -36.78 | -66.81 | -66.87 | -79.33 | ||||
Long Term Solvency | |||||||||
Total Debt/Equity | 19.27 | 32 | 36.69 | 39.54 | 32.31 | ||||
Total Debt / Total Capital | 16.16 | 24.24 | 26.84 | 28.34 | 24.42 | ||||
LT Debt/Equity | 18.79 | 31.4 | 35.34 | 38.12 | 29.44 | ||||
Long-Term Debt / Total Capital | 15.75 | 23.79 | 25.85 | 27.32 | 22.25 | ||||
Total Liabilities / Total Assets | 22.51 | 29.18 | 31.43 | 33.21 | 29.57 | ||||
EBIT / Interest Expense | -3.68 | -1.63 | -1.05 | -0.3 | 0.34 | ||||
EBITDA / Interest Expense | -2.9 | -1.11 | -0.71 | -0.01 | 0.58 | ||||
(EBITDA - Capex) / Interest Expense | -3.3 | -1.64 | -1.12 | -0.09 | 0.43 | ||||
Total Debt / EBITDA | -10.97 | -36.09 | -41.66 | -2.04K | 51.47 | ||||
Net Debt / EBITDA | -3.02 | -5.8 | 11.46 | 332.75 | -7.4 | ||||
Total Debt / (EBITDA - Capex) | -9.63 | -24.5 | -26.32 | -326.56 | 69.42 | ||||
Net Debt / (EBITDA - Capex) | -2.65 | -3.94 | 7.24 | 53.24 | -9.99 | ||||
Growth Over Prior Year | |||||||||
Total Revenues, 1 Yr. Growth % | 53.63 | 34.21 | 10.44 | 10.51 | 12.86 | ||||
Gross Profit, 1 Yr. Growth % | 44.06 | 24.14 | 20.86 | 35.74 | 18.09 | ||||
EBITDA, 1 Yr. Growth % | 68.31 | -38.15 | -28.75 | -94.59 | -3.56K | ||||
EBITA, 1 Yr. Growth % | 65.12 | -34.8 | -26.12 | -59.66 | -346.88 | ||||
EBIT, 1 Yr. Growth % | 60.23 | -32.58 | -22.16 | -45.42 | -212.57 | ||||
Earnings From Cont. Operations, 1 Yr. Growth % | 102.05 | 151.3 | -48.87 | -29.39 | 82.13 | ||||
Net Income, 1 Yr. Growth % | 97.53 | 151.48 | -46.02 | -34.67 | 87.21 | ||||
Normalized Net Income, 1 Yr. Growth % | 75.17 | 39.56 | -44.65 | -37.32 | 103.76 | ||||
Diluted EPS Before Extra, 1 Yr. Growth % | 97.51 | 173.45 | -43.28 | -25.42 | 183.98 | ||||
Accounts Receivable, 1 Yr. Growth % | 35.14 | 84 | -0.48 | 21.29 | 11.91 | ||||
Inventory, 1 Yr. Growth % | 50.7 | 46.42 | -31.06 | -17.28 | -4.85 | ||||
Net Property, Plant and Equip., 1 Yr. Growth % | 17.51 | 36.34 | 2.65 | -10.48 | -11.17 | ||||
Total Assets, 1 Yr. Growth % | 55.82 | 28.01 | -8.78 | -5 | 17.42 | ||||
Tangible Book Value, 1 Yr. Growth % | 54.04 | 14.77 | -7.17 | -6.79 | 24.02 | ||||
Common Equity, 1 Yr. Growth % | 48 | 17.07 | -11.56 | -7.47 | 23.72 | ||||
Cash From Operations, 1 Yr. Growth % | -176.08 | -480.5 | -80.17 | -970.83 | 83.73 | ||||
Capital Expenditures, 1 Yr. Growth % | 32.91 | 101.9 | 8.02 | -81.66 | 97.62 | ||||
Levered Free Cash Flow, 1 Yr. Growth % | -1.46K | -136.14 | 93.39 | -74.77 | -255.93 | ||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 85.34K | -120.74 | 112.64 | -94.35 | -1.43K | ||||
Dividend Per Share, 1 Yr. Growth % | 35.86 | -5.31 | -2.24 | 105.11 | 100.37 | ||||
Compound Annual Growth Rate Over Two Years | |||||||||
Total Revenues, 2 Yr. CAGR % | 38.81 | 43.59 | 6.15 | 2.34 | 11.68 | ||||
Gross Profit, 2 Yr. CAGR % | 25.48 | 33.73 | -0.12 | 27.31 | 26.61 | ||||
EBITDA, 2 Yr. CAGR % | 64.58 | 2.84 | -25.52 | -88.88 | 36.81 | ||||
EBITA, 2 Yr. CAGR % | 61.42 | 4.55 | -24.35 | -62.15 | -0.21 | ||||
EBIT, 2 Yr. CAGR % | 52.52 | 4.63 | -22.71 | -52.78 | -21.62 | ||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 31.98 | 125.33 | 13.19 | -39.17 | 13.4 | ||||
Net Income, 2 Yr. CAGR % | 44.23 | 122.88 | 16.51 | -40.62 | 10.59 | ||||
Normalized Net Income, 2 Yr. CAGR % | 37.48 | 56.19 | -12.62 | -39.83 | 13.05 | ||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 31.11 | 132.45 | 24.37 | -9.48 | 45.53 | ||||
Accounts Receivable, 2 Yr. CAGR % | 5.41 | 57.69 | 17.19 | 75.56 | 16.51 | ||||
Inventory, 2 Yr. CAGR % | 47.27 | 48.55 | 0.47 | -24.49 | -11.28 | ||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 76.01 | 26.58 | 18.3 | -4.14 | -10.83 | ||||
Total Assets, 2 Yr. CAGR % | 29.97 | 41.23 | 8.06 | -6.91 | 5.61 | ||||
Tangible Book Value, 2 Yr. CAGR % | 28.28 | 32.96 | 3.22 | -6.98 | 7.52 | ||||
Common Equity, 2 Yr. CAGR % | 25.72 | 31.63 | 1.75 | -9.54 | 6.99 | ||||
Cash From Operations, 2 Yr. CAGR % | 4.72 | 70.14 | -13.13 | 31.43 | 300 | ||||
Capital Expenditures, 2 Yr. CAGR % | -0.47 | 63.82 | 47.68 | -55.49 | -39.8 | ||||
Levered Free Cash Flow, 2 Yr. CAGR % | 33.37 | 121.33 | -0.76 | -33.09 | -37.28 | ||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 48.21 | 1.23K | -14.36 | -67.12 | -13.24 | ||||
Dividend Per Share, 2 Yr. CAGR % | - | 13.42 | -3.79 | 22.92 | 102.72 | ||||
Compound Annual Growth Rate Over Three Years | |||||||||
Total Revenues, 3 Yr. CAGR % | 30.48 | 37.26 | 20.07 | 2.24 | 5.73 | ||||
Gross Profit, 3 Yr. CAGR % | 21.81 | 25.03 | 12.85 | 10.19 | 24.16 | ||||
EBITDA, 3 Yr. CAGR % | 17.6 | 19.39 | -1.74 | -78.73 | -24.63 | ||||
EBITA, 3 Yr. CAGR % | 17.37 | 19.93 | -1.38 | -51.94 | -29.28 | ||||
EBIT, 3 Yr. CAGR % | 16.44 | 16.7 | -1.01 | -44.48 | -36.92 | ||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -13.3 | 63.58 | 37.31 | -2.49 | -12.33 | ||||
Net Income, 3 Yr. CAGR % | -13.44 | 73.59 | 38.93 | -3.92 | -12.93 | ||||
Normalized Net Income, 3 Yr. CAGR % | 37.33 | 38.08 | 10.1 | -20.66 | -9.63 | ||||
Diluted EPS Before Extra, 3 Yr. CAGR % | - | 67.54 | 45.12 | 30.73 | 32.51 | ||||
Accounts Receivable, 3 Yr. CAGR % | -3.9 | 26.92 | 22.89 | 62.02 | 51.09 | ||||
Inventory, 3 Yr. CAGR % | 32.18 | 46.99 | 15.01 | -5.84 | -18.44 | ||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 66.49 | 61.65 | 18.04 | 7.8 | -6.54 | ||||
Total Assets, 3 Yr. CAGR % | 20.84 | 29.31 | 22.09 | 3.52 | 0.58 | ||||
Tangible Book Value, 3 Yr. CAGR % | 24.26 | 23.61 | 17.96 | -0.23 | 2.38 | ||||
Common Equity, 3 Yr. CAGR % | 21.38 | 22.77 | 15.29 | -1.42 | 0.41 | ||||
Cash From Operations, 3 Yr. CAGR % | -17.09 | 60.99 | -16.89 | 87.32 | 46.95 | ||||
Capital Expenditures, 3 Yr. CAGR % | 17.33 | 25.99 | 42.58 | -26.32 | -26.84 | ||||
Levered Free Cash Flow, 3 Yr. CAGR % | 29.55 | -13.83 | 137.24 | -38.91 | -11.29 | ||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 27.47 | -23.15 | 754.6 | -66.59 | 12.91 | ||||
Dividend Per Share, 3 Yr. CAGR % | - | - | 7.94 | 12.68 | 44.67 | ||||
Compound Annual Growth Rate Over Five Years | |||||||||
Total Revenues, 5 Yr. CAGR % | - | 30.2 | 20.14 | 15.54 | 13.13 | ||||
Gross Profit, 5 Yr. CAGR % | - | 24.15 | 12.51 | 16.06 | 17.88 | ||||
EBITDA, 5 Yr. CAGR % | - | -5.23 | -1.73 | -51.63 | -10.63 | ||||
EBITA, 5 Yr. CAGR % | - | -3.82 | -1.25 | -21.74 | -14.41 | ||||
EBIT, 5 Yr. CAGR % | - | -3.57 | -0.9 | -16.6 | -20.74 | ||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | 122.89 | -3.55 | 10.06 | 27.82 | ||||
Net Income, 5 Yr. CAGR % | - | 48.36 | -2.51 | 13.03 | 26.81 | ||||
Normalized Net Income, 5 Yr. CAGR % | - | 71.9 | 14.57 | -1.19 | 12.22 | ||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | - | 30.9 | 65.82 | ||||
Accounts Receivable, 5 Yr. CAGR % | - | 14.87 | 4.04 | 36.43 | 45.1 | ||||
Inventory, 5 Yr. CAGR % | - | 37.97 | 18.44 | 12.61 | 3.66 | ||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | 61.49 | 45.22 | 31.16 | 5.51 | ||||
Total Assets, 5 Yr. CAGR % | - | 31.88 | 15.56 | 13.38 | 15.21 | ||||
Tangible Book Value, 5 Yr. CAGR % | - | 41.72 | 15.37 | 10.32 | 13.66 | ||||
Common Equity, 5 Yr. CAGR % | - | 34.98 | 13.11 | 8.65 | 11.9 | ||||
Cash From Operations, 5 Yr. CAGR % | - | 8.3 | -15.53 | 48.44 | 55.82 | ||||
Capital Expenditures, 5 Yr. CAGR % | - | 38.23 | 28.64 | -16.9 | 0.99 | ||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | 16.35 | -16.59 | 36.97 | ||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | 8.63 | -39.42 | 235.1 | ||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | - | 31.25 |
- Stock Market
- Equities
- PRX Stock
- Financials Prosus N.V.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















